Company intelligence / Profile preview
Tikun Olam
Israeltikun-olam.org.il ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
Tikun Olam has developed 42 award-winning proprietary cannabis strains and conducted 35 clinical and preclinical studies in collaboration with leading doctors, hospitals, and universities in Israel
- Therapeutic areas
- OncologyPsychiatryGastroenterologyNeurologyInfectious Diseases
- Modalities
- Medical cannabis products
- Industry
- Biotech
02
Drug pipeline
8 assets7 more assets in the full pipeline.
Beyond the preview
Go deeper on Tikun Olam.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Tikun Olam.